To further investigate the impact of peripheral MCP-1 on AD brain pathology, the relationships between blood MCP-1, selected variants, and three neuropathology features were evaluated using ordinal regression in the FHS, in which 78 participants donated their brain after death. This evidence concerns the gene CCL2 and Alzheimer disease.